GlassScriptPhysician profile
John O Schrader
NPI 1710105077
$7,075.21
in general payments reported to CMS, 2019-2025
35 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $277 · 2021: $1,278 · 2022: $1,037 · 2023: $874 · 2024: $2,123 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,483 · Travel and Lodging: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,483.17 |
| Travel and Lodging | $1,149.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,261.22 | 2021-2025 | Selectsecure, Cobalt Dr Mri Surescan, Micra |
| Merck Sharp & Dohme LLC | $717.28 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $715.67 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Novartis Pharmaceuticals Corporation | $418.50 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $402.32 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $390.96 | 2019-2023 | Xarelto |
| Amgen INC. | $280.63 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.40 | 2019-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.27 | 2019-2024 | Lifevest |
| Cvrx, INC. | $193.86 | 2021-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $124.56 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $123.19 | 2020-2022 | |
| Heartflow, INC. | $118.98 | 2019 | |
| Amarin Pharma, INC. | $96.41 | 2019-2022 | |
| Philips North America LLC | $68.33 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $68.01 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $65.42 | 2024-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $59.64 | 2019-2024 | Evkeeza |
| Baxter Healthcare | $58.17 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $51.67 | 2019 | |
| Novo Nordisk INC | $42.30 | 2022-2023 | Rybelsus, Ozempic |
| Atricure, INC. | $40.56 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $39.98 | 2022 | |
| Edwards Lifesciences Corporation | $35.90 | 2024 | |
| Tactile Systems Technology INC | $31.17 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Sanofi-Aventis U.S. LLC | $28.76 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $28.70 | 2021 | |
| Kerecis Limited | $25.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Esperion Therapeutics, INC. | $24.76 | 2021 | |
| Endologix LLC | $23.72 | 2025 | Endocross Device, Torus Stent Graft System |
| Scpharmaceuticals INC. | $19.19 | 2023 | |
| Medtronic Vascular, INC. | $17.63 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $13.08 | 2024 | Arcalyst |
| Cardinal Health 200 LLC | $11.47 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schrader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.